Louisiana HB 373 would create a tightly controlled adult-use cannabis pilot overseen by the Louisiana Department of Health. The bill limits participation to existing medical marijuana dispensaries, imposes permit renewal fees and a 3.5 percent wholesale assessment, and sunsets July 1, 2030, forcing lawmakers to decide whether to make legalization permanent.
THE MONEY BEHIND CANNABIS PROHIBITION
Cannabis prohibition in the United States no longer survives on raids and panic films. It survives through ballot thresholds, legislative rewrites, regulatory choke points, and lobbying disclosures. This documented audit follows the filings behind legalization war chests, opposition strategies, and the institutional structures that still shape cannabis policy even after voters move on.
Why Illegal Weed Thrives in Legal Cannabis Markets
Nevada’s legal cannabis market runs in plain sight, yet unlicensed sales keep pace because the rules still leave openings. Price gaps, compliance costs, patchy access, and limited places to consume make the illicit channel feel easier for many buyers. This feature tracks what the numbers show, why raids only disrupt, and what actually shrinks underground sales.
The Drug Test Lie Finally Cracks in New Mexico
New Mexico’s Senate Bill 129 challenges the long-standing assumption that a positive cannabis test equals impairment. By separating outdated drug testing from actual workplace safety, the bill aims to protect medical cannabis patients from job discrimination while preserving employer authority over real on-the-job risk and misconduct.
How Cannabis Can Cost You Your Gun
Federal law still allows cannabis use to strip Americans of firearm rights without proof of danger or misuse. As the Supreme Court weighs United States v. Hemani, courts are confronting whether the government can continue punishing people based on status rather than conduct in a country where cannabis is legal in most states.
Reefer Report Card Vol. 32: Kicking the Can Again
This week’s Reefer Report Card tracks a familiar pattern in cannabis policy: delay dressed as progress. Federal lawmakers punted again on hemp regulation, states flirted with dismantling legal markets, and patients were left waiting. Oversight weakened, accountability faded, and reform stalled. Another week in weed, graded.